Parallel Advisors’s Avita Medical RCEL Stock Holding History

Parallel Advisors’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$165	Hold	40	–	–	﹤0.01%	3858
2026 Q1	$148	Hold	40	–	–	﹤0.01%	3770
2025 Q4	$138	Hold	40	–	–	﹤0.01%	3536
2025 Q3	$204	Hold	40	–	–	﹤0.01%	3439
2025 Q2	$212	Hold	40	–	–	﹤0.01%	3416
2025 Q1	$326	Hold	40	–	–	﹤0.01%	3313
2024 Q4	$512	Hold	40	–	–	﹤0.01%	3221
2024 Q3	$429	Hold	40	–	–	﹤0.01%	3205
2024 Q2	$317	Hold	40	–	–	﹤0.01%	3149
2024 Q1	$641	Hold	40	–	–	﹤0.01%	3013
2023 Q4	$549	Hold	40	–	–	﹤0.01%	3045
2023 Q3	$584	Hold	40	–	–	﹤0.01%	3078
2023 Q2	$680	Hold	40	–	–	﹤0.01%	3030
2023 Q1	$559	Hold	40	–	–	﹤0.01%	3090
2022 Q4	$264	Hold	40	–	–	﹤0.01%	3147
2022 Q3	$0	Hold	40	–	–	﹤0.01%	3430
2022 Q2	$0	Hold	40	–	–	﹤0.01%	3287
2022 Q1	$0	Hold	40	–	–	﹤0.01%	3217
2021 Q4	$0	Hold	40	–	–	﹤0.01%	3250
2021 Q3	$1K	Hold	40	–	–	﹤0.01%	2938
2021 Q2	$1K	Hold	40	–	–	﹤0.01%	2806
2021 Q1	$1K	Buy	+40	New	+$930	﹤0.01%	2677

Other funds holding RCEL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TDC

Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

R Squared Central, Hong Kong $190M AUM 25.89% 1-Year Est. Return

AHL

Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return

nVerses Capital Wellington, Florida $65M AUM

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Parallel Advisors's RCEL Position: Q2 2026 in Review

Parallel Advisors held its Avita Medical (RCEL) position steady in Q2 2026 at 40 shares worth $165. The position accounts for ﹤0.01% of the portfolio, ranked #3858.

Parallel Advisors first reported a position in RCEL in Q1 2021 and has held it in 22 quarters since. The position peaked at $1K in Q3 2021. 24 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

Parallel Advisors held 40 shares of Avita Medical worth $165 as of Q2 2026.
Parallel Advisors left its Avita Medical share count unchanged in Q2 2026.
Avita Medical made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3858 holding.
Parallel Advisors first reported a position in Avita Medical in Q1 2021 and has held it in 22 quarters since.
Parallel Advisors's Avita Medical position peaked at $1K in Q3 2021.
24 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.